Covid -19 IgG/IgM rapid antibody test for detection of IgG and IgM antibodies in human serum/plasma/Whole blood
- UID
- MFG/IVD/2020/000161_77018fc72f2fd559b5c1d0ea07877631_c1ca2954ab29dac396dbf85c1ef63ff5
- Device class
- Class C
- Brand name
- EzDx
- License holder
- ADVY CHEMICAL PVT. LTD.
- Approving authority
- Central Drug Standards Control Organization, West Zone
- Product information
- EzDx COVID-19 antibody detection rapid kit is a rapid and qualitative immune-chromatographic in vitro assay for the differential detection of IgM & IgG antibodies to COVID-19 virus in human serum, plasma/whole blood samples obtained from patient with signs and symptoms of respiratory infection. It is designed for qualitative detection of Immunoglobulin G and Immunoglobulin M antibody of Novel Coronavirus (EzDx) in human blood. The test is intended for professional and laboratory use
Covid -19 IgG/IgM rapid antibody test for detection of IgG and IgM antibodies in human serum/plasma/Whole blood is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000161_77018fc72f2fd559b5c1d0ea07877631_c1ca2954ab29dac396dbf85c1ef63ff5. This device is marketed under the brand name EzDx. The license holder is ADVY CHEMICAL PVT. LTD., and it is classified as Device Class Class C. The approving authority is Central Drug Standards Control Organization, West Zone.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.